Rw charlie turner resume oct 13

ROBERT W. (CHARLIE) TURNER
(919) 362-4483 home • (919) 418-3874 mobile SENIOR-LEVEL BIOPHARMACEUTICAL EXECUTIVE
BUSINESS DEVELOPMENT / LICENSING / STRATEGIC & FINANCIAL MANAGEMENT
MBA, CPA, CGMA, Certified Licensing Professional™ (CLP)

• Accomplished biopharmaceutical business professional with deep expertise in business development,
licensing, strategic alliances, and strategic / financial management. • Key role in 30+ biopharma deals with cumulative value exceeding $1.5 billion (Deal Sheet available). • Led/coordinated key BD&L processes including partner/opportunity search, commercial assessment, valuation & analysis, term sheet development, due diligence, deal term negotiations and closing. • Pharmaceutical Corporate Finance roles included domestic and international operating unit planning, reporting & analysis; controller of regional business operations; manager of marketing finance; international treasury operations. • Extensive biopharmaceutical industry business development contacts. EXPERIENCE

Tri-Bio Ventures LLC, Cary, NC
2009 - present
President and Principal Consultant
Tri-Bio Ventures is a biopharmaceutical business development and licensing consulting practice
www.tribioventures.com
• Founded and organized wholly-owned consulting practice in February 2009.
• Lead advisor on commercial partnering of client’s hemophilia gene therapy program with Baxter Intl.
• Led successful out-licensing of platform technology to Pfizer and AMT/uniQure (a Dutch biotech co.).
• Led and executed in-licensing, option and research collaboration agreement with ReGenX Biosciences.
• Led BD outreach resulting in 110 new contacts & over 50 meetings for BioDelivery Sciences (BDSI).

POZEN Inc., Chapel Hill, NC
2001 - 2009
Vice President, Business Development
POZEN is a small (~35 employees) outsource-model specialty pharmaceutical company
• Executed three out-licensing/ commercialization agreements with combined value exceeding $600MM
+ royalties. Two products (TREXIMET® and Vimovo™) are now marketed by GSK and AstraZeneca. • Identified and screened over 250 in-licensing opportunities and made recommendations to management, resulting in leading the completion of complex option, in-licensing & supply agreements for rights to a Phase II NSAID product from Nycomed. • Completed an exclusive manufacturing & supply agreement for a proprietary active drug substance. • Performed financial analyses & valuations, developed deal structures & internal proposals, led cross- functional teams, coordinated due diligence, and negotiated deal terms.
Pappas Ventures, Research Triangle Park, NC
1999 - 2001
Vice President, Transaction Advisory Services
Pappas Ventures is a life sciences venture capital firm that also offers consulting advisory services
• Provided business development and licensing advisory services to a broad range of clients, including
large & mid-sized pharmaceutical companies, biotech startups and biopharma service providers. • Conducted analyses/valuations for consulting clients and selected venture capital investments. • Advised King Pharmaceuticals on ALTACE® co-promotion agreement with Wyeth worth over $150MM + royalties, generating firm’s largest transaction success fee in over three years. Novartis Consumer Health, Summit, NJ
Director, Global Business Development & Licensing
• Led OTC division licensing and M&A projects originating in the U.S.
• Negotiated and executed option to in-license an OTC product in early development.
ROBERT W. (CHARLIE) TURNER

GlaxoSmithKline, Research Triangle Park, NC
1991 - 1999
Director, Business Development, 1996 - 1999
• Led five separate product divestiture transactions, including 12 brands, for value exceeding $180MM.
• Directed U.S. subsidiary input into in-licensing of global rights to RAXAR® a Phase II compound from
Otsuka (Japan), including negotiation of royalty rates applicable to future U.S. product sales. • Contributed to anti-infectives therapeutic area strategy team as sole business development member. • Promoted from manager to director.
Manager of Finance, Marketing / Controller, Business Operations, 1994 - 1996
• Provided financial reporting, analysis and strategic planning to U.S. marketing division, seven regional
business units and sales administration support services. Managed three employees. Promoted. • Performed analysis and valuation of a potential acquisition target company as sole financial representative on a cross-functional acquisition team.
Senior Budget/Planning/Business Analyst, 1991 - 1994
• Coordinated, compiled and analyzed financial plans for U.S. operations. Three promotions.
• Assisted in preparation and analysis of U.S. corporate strategic business plan.
• Provided analysis and valuations for several potential product licensing transactions.

Eli Lilly and Company, Indianapolis, IN
1989 - 1991
Financial Analyst
• Managed accounting and analysis of foreign exchange transactions, cash management, and strategic
currency hedging. Implemented quarterly treasury stock repurchase program. Three direct reports. • Coordinated, analyzed and presented animal health division annual and long-range business plans. • Participated on marketing launch and strategy teams for Micotil® new product launch. • Performed manufacturing cost analyses that resulted in over $800k annual savings. • Prepared analysis and valuation for divestiture of Lilly subsidiary company.
Ernst & Young, Winston-Salem, NC
1985 - 1987
Staff Accountant
• Financial auditor of publicly-held, private and governmental entities.
EDUCATION / PROFESSIONAL CERTIFICATIONS

Master of Business Administration (MBA), 1989
The University of North Carolina - Kenan-Flagler Business School, Chapel Hill, NC
• Co-chairman of International Business Committee - MBA Student Association.

Bachelor of Science (BS) in Accounting, 1985
Brigham Young University - Marriott School of Management, Provo, UT
• Beta Alpha Psi, honorary accounting fraternity.

Certified Licensing Professional™ (CLP), designation earned in 2008 (inaugural certification year).
Chartered Global Management Accountant (CGMA), designation earned in 2013.
Certified Public Accountant (CPA), licensed in NC since 1987.
ADDITIONAL INFORMATION

• Licensing Executives Society (LES), member since 1996.
• American Institute of Certified Public Accountants (AICPA), member since 1987.
• Full-time volunteer service work in Brazil, 1981 – 1982.
Ø Management, Leadership, Training, Teaching, Coordinated Service. • Fluent in Portuguese; conversant in Spanish.

Source: http://www.tribioventures.com/docs/RW_Charlie_Turner_Resume.pdf